Viscosity is a principal parameter when any flow measurements of fluids, such as liquids, semi-solids, gases, and even solids are made.

Indeed, many drug manufacturers now regard viscosity readings as a crucial part of their research, development, and process control programs as it enables them the ability to predict how a material will behave in the real world across varying temperatures.

Recognized as often the quickest, most accurate, and reliable way to analyze some of the most important factors affecting product performance, QUINTA-ANALYTICA are excited to receive delivery of the very latest piece of tech in this key area, the top of the range, AMETEK Brookfield RVDV2T viscometer.

This key investment unlocks measuring capabilities ranging from ultra-low viscosity inks, oils, and solvents, through to gels, epoxies, asphalt, and molasses at the opposite end of the scale. It’s fair to say that armed with this impressive piece of tech, in addition to our existing line-up, Quinta is your true A-Z pharma partner.

Get in touch with our team to discover the full range of services.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.